Case of recurrent Sweet's syndrome in a patient with relapsing polychondritis and myelodysplastic syndrome. 2012

Ken Washio, and Masahiro Oka, and Kentaro Ohno, and Hideki Shimizu, and Seiji Kawano, and Makoto Kunisada, and Chikako Nishigori

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009190 Myelodysplastic Syndromes Clonal hematopoietic stem cell disorders characterized by dysplasia in one or more hematopoietic cell lineages. They predominantly affect patients over 60, are considered preleukemic conditions, and have high probability of transformation into ACUTE MYELOID LEUKEMIA. Dysmyelopoietic Syndromes,Hematopoetic Myelodysplasia,Dysmyelopoietic Syndrome,Hematopoetic Myelodysplasias,Myelodysplasia, Hematopoetic,Myelodysplasias, Hematopoetic,Myelodysplastic Syndrome,Syndrome, Dysmyelopoietic,Syndrome, Myelodysplastic,Syndromes, Dysmyelopoietic,Syndromes, Myelodysplastic
D011081 Polychondritis, Relapsing An acquired disease of unknown etiology, chronic course, and tendency to recur. It is characterized by inflammation and degeneration of cartilage and can result in deformities such as floppy ear and saddle nose. Loss of cartilage in the respiratory tract can lead to respiratory obstruction. Polychondritis, Chronic Atrophic,Atrophic Polychondritides, Chronic,Atrophic Polychondritis, Chronic,Chronic Atrophic Polychondritides,Chronic Atrophic Polychondritis,Polychondritides, Chronic Atrophic,Polychondritides, Relapsing,Relapsing Polychondritides,Relapsing Polychondritis
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D016463 Sweet Syndrome Condition characterized by large, rapidly extending, erythematous, tender plaques on the upper body usually accompanied by fever and dermal infiltration of neutrophilic leukocytes. It occurs mostly in middle-aged women, is often preceded by an upper respiratory infection, and clinically resembles ERYTHEMA MULTIFORME. Sweet syndrome is associated with LEUKEMIA. Dermatosis, Neutrophilic, Febrile, Acute,Neutrophilic Dermatosis, Acute Febrile,Sweet's Syndrome,Acute Febrile Neutrophilic Dermatosis,Gomm Button Disease,Gomm-Button Disease,Disease, Gomm Button,Disease, Gomm-Button,Sweets Syndrome,Syndrome, Sweet,Syndrome, Sweet's
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes

Related Publications

Ken Washio, and Masahiro Oka, and Kentaro Ohno, and Hideki Shimizu, and Seiji Kawano, and Makoto Kunisada, and Chikako Nishigori
January 2011, Anais brasileiros de dermatologia,
Ken Washio, and Masahiro Oka, and Kentaro Ohno, and Hideki Shimizu, and Seiji Kawano, and Makoto Kunisada, and Chikako Nishigori
November 1990, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Ken Washio, and Masahiro Oka, and Kentaro Ohno, and Hideki Shimizu, and Seiji Kawano, and Makoto Kunisada, and Chikako Nishigori
March 2017, The American journal of medicine,
Ken Washio, and Masahiro Oka, and Kentaro Ohno, and Hideki Shimizu, and Seiji Kawano, and Makoto Kunisada, and Chikako Nishigori
October 2004, International journal of dermatology,
Ken Washio, and Masahiro Oka, and Kentaro Ohno, and Hideki Shimizu, and Seiji Kawano, and Makoto Kunisada, and Chikako Nishigori
January 2007, Acta dermato-venereologica,
Ken Washio, and Masahiro Oka, and Kentaro Ohno, and Hideki Shimizu, and Seiji Kawano, and Makoto Kunisada, and Chikako Nishigori
November 1998, The British journal of dermatology,
Ken Washio, and Masahiro Oka, and Kentaro Ohno, and Hideki Shimizu, and Seiji Kawano, and Makoto Kunisada, and Chikako Nishigori
July 1993, American journal of hematology,
Ken Washio, and Masahiro Oka, and Kentaro Ohno, and Hideki Shimizu, and Seiji Kawano, and Makoto Kunisada, and Chikako Nishigori
June 2001, The Journal of laryngology and otology,
Ken Washio, and Masahiro Oka, and Kentaro Ohno, and Hideki Shimizu, and Seiji Kawano, and Makoto Kunisada, and Chikako Nishigori
November 2020, Rheumatology (Oxford, England),
Ken Washio, and Masahiro Oka, and Kentaro Ohno, and Hideki Shimizu, and Seiji Kawano, and Makoto Kunisada, and Chikako Nishigori
January 2008, Acta dermato-venereologica,
Copied contents to your clipboard!